Blood Test Using Patient’s Unique Genetic Signature Appears To Show Some Ability To Predict Nonresponse To TNF Inhibitors As Treatment For RA, Study Indicates

Rheumatology News (8/13, Kirkner) reported, “A blood test that uses a patient’s unique genetic signature has shown some ability to predict nonresponse to tumor necrosis factor [TNF] inhibitors as treatment for rheumatoid arthritis [RA],” investigators con...